Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

Sugar Defender Reviews (URGENT REPORT) The Shocking Truth About Craving Control, Energy & Glucose Support
Healthcare & PharmaceuticalAdvertorial

Sugar Defender Reviews (URGENT REPORT) The Shocking Truth About Craving Control, Energy & Glucose Support

December 3, 2025 4:55 PM

In 2025, blood sugar instability has become one of the most quietly damaging health frustrations people face, and one of the most misunderstood. Energy crashes, cravings, irritability, focus problems, and fluctuating weight patterns are increasingly linked to mild but persistent glucose volatility. It's no surprise that millions are turning to non-prescription blood sugar support formulas in search of something simple, natural, and sustainable....

Read more
2026 New Remote Patient Monitoring (RPM) CPT Codes
Healthcare & PharmaceuticalProduct Announcements

2026 New Remote Patient Monitoring (RPM) CPT Codes

December 3, 2025 3:00 PM

The 2026 CMS Final Rule introduces a major milestone in digital healthcare, expanding flexibility and reimbursement options for Remote Patient Monitoring (RPM). As part of the updated Physician Fee Schedule (PFS), CMS has finalized two new CPT codes that give providers more precise billing pathways for shorter monitoring durations and reduced management time, supporting patient-centered care for both chronic and acute conditions. Introducing CPT...

Read more
P. Hemachandra Reddy Calls for Greater Support in Expanding Student Mentorship and Early-Career Scientific Guidance
Healthcare & PharmaceuticalCompany Name Change

P. Hemachandra Reddy Calls for Greater Support in Expanding Student Mentorship and Early-Career Scientific Guidance

December 3, 2025 3:00 PM

Dr. Hemachandra Reddy, longtime professor and Fellow of multiple national scientific organizations, is raising awareness about the urgent need for stronger student mentorship and early-career support in science, technology, engineering, and medical research. Drawing from nearly three decades of academic and research leadership, Dr. Reddy is advocating for a community-driven effort to provide students with access to experienced scientific...

Read more
Brian Moran Cancer Institute to Open December 15, 2025
Healthcare & PharmaceuticalCompany Update

Brian Moran Cancer Institute to Open December 15, 2025

December 3, 2025 3:00 PM

Duly Health and Care, through one of its med­ical groups, DuPage Med­ical Group, Ltd., is proud to announce that the Bri­an Moran Can­cer Insti­tute (BMCI) will offi­cial­ly open on Decem­ber 15, 2025, expand­ing access to world-class can­cer care across Chicagoland. The Insti­tute will bring togeth­er advanced clin­i­cal care, research, and patient nav­i­ga­tion through­out a coor­di­nat­ed sys­tem designed to serve patients close to home. The...

Read more
Hospital Cybersecurity Leaders Identify Non-Negotiable Domains to Fund by 2028
Healthcare & PharmaceuticalPartnerships

Hospital Cybersecurity Leaders Identify Non-Negotiable Domains to Fund by 2028

December 3, 2025 1:30 PM

A new Black Book™ flash survey of 211 U.S. hospital and health system IT and cybersecurity leaders finds that a small set of cybersecurity domains has become "non-negotiable" for funding between 2026 and 2028 if clinical operations are to remain safe and financially viable. The survey, conducted in November 2025, asked CIOs, CISOs, CTOs, and security leaders to identify their top acquisition and expansion priorities for 2026 and to project which...

Read more
iTolerance, Inc. Releases Next Video in Its Patient Journey Series Highlighting the Real-Life Impact of Type 1 Diabetes
Healthcare & PharmaceuticalCompany Update

iTolerance, Inc. Releases Next Video in Its Patient Journey Series Highlighting the Real-Life Impact of Type 1 Diabetes

December 3, 2025 10:30 AM

iTolerance, Inc. ("iTolerance" or the "Company"), an early-stage privately-held biotechnology company focused on the development of innovative regenerative medicines, today announced the release of the next segment in its Patient Journey video series featuring Kristen and Raul, parent and grandparent, respectively, of a child with Type 1 Diabetes. As part of the segment, Kristen shares about her daughter's Type 1 Diabetes diagnosis, the impact...

Read more
Medical Care Technologies Inc. (OTC Pink:MDCE) Slashes Costs, Outsmarts Industry Giants with Lean AI Innovation Model
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTC Pink:MDCE) Slashes Costs, Outsmarts Industry Giants with Lean AI Innovation Model

December 3, 2025 9:30 AM

Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to highlight its strategic advantage of operating as a lean, agile company in the competitive AI sector. While many large public companies in the artificial intelligence industry invest hundreds of millions-or even billions-of dollars into infrastructure, proprietary data centers, and in-house development, MDCE has chosen a different path. By leveraging outsourcing for hosting and...

Read more
GAT Sport Launches Zero-Sugar Creatine Chews: 5g of Pure Muscle Energy, No Shaker Needed
Healthcare & PharmaceuticalProduct Announcements

GAT Sport Launches Zero-Sugar Creatine Chews: 5g of Pure Muscle Energy, No Shaker Needed

December 3, 2025 9:00 AM

GAT Sport (www.gatsport.com), a global leader in performance nutrition trusted by professional athletes, physique buffs and amateur fitness fanatics for more than a quarter-century, today announced the release of its newest innovation Creatine Chews, a zero-sugar, chewable supplement that delivers 5 grams of pure creatine monohydrate per serving for maximum strength, muscle mass, and power on the go. With GAT Sport Creatine Chews, you get a full...

Read more
New Horizon Medical Solutions Announces Exclusive US Partnership with Kent Imaging
Healthcare & PharmaceuticalPartnerships

New Horizon Medical Solutions Announces Exclusive US Partnership with Kent Imaging

December 3, 2025 9:00 AM

New Horizon Medical Solutions (NHMS) today announced it has secured exclusive U.S. distribution rights - across all 48 contiguous states - for Kent Imaging's full lineup of advanced wound-care imaging technologies. This agreement grants NHMS the sole authority to market, promote and distribute Kent Imaging's complete portfolio within the nation's largest clinical systems and care venues. Kent Imaging continues to accelerate its momentum with the...

Read more
What Leads to Gum Recession? Dr. Gallardo Breaks Down Key Contributing Factors
Healthcare & PharmaceuticalCompany Update

What Leads to Gum Recession? Dr. Gallardo Breaks Down Key Contributing Factors

December 3, 2025 8:00 AM

Gum recession is one of the most common oral health concerns among adults, yet many people are unaware of what causes it or why it progresses differently from one person to another. As more patients seek evaluation for symptoms like tooth sensitivity, exposed roots, and changes in their gumline, understanding the underlying factors becomes an important step in protecting oral health. Renowned Miami periodontist Dr. John Paul Gallardo of Gallardo...

Read more
Hoggan Scientific, LLC Receives U.S. Department of Veterans Affairs Federal Supply Schedule (FSS) Contract
Healthcare & PharmaceuticalAwards

Hoggan Scientific, LLC Receives U.S. Department of Veterans Affairs Federal Supply Schedule (FSS) Contract

December 3, 2025 7:00 AM

Hoggan Scientific, LLC a leading manufacturer and innovator of medical dynamometers, announces that it has been awarded a VA Federal Supply Schedule Contract (FSS 65IIA) under Medical Equipment and Supplies by the U.S. Veteran's Administration. The company's contract number is 36F797D0251, effective 10/15/2025 through 10/14/2030, for its microFET line of diagnostic and evaluation products. The FSS Contract streamlines the procurement process for...

Read more
NEI Announces Grand Opening Presentation:
Healthcare & PharmaceuticalAdvertorial

NEI Announces Grand Opening Presentation: "Women, Menopause, and the Endocannabinoid System"

December 3, 2025 7:00 AM

The Neurodivergent Empowerment Institute (NEI) is proud to feature Heather Reilly Hiemstra as a headline speaker at its Grand Opening Wellness Event on Sunday, December 14, 2025, hosted at NEI's new flagship location: 2200 2nd Ave S, Suite 134, St. Petersburg, FL. Reilly Hiemstra will present "Women, Menopause, Sex, and the Endocannabinoid System", a timely and foundational talk exploring how the endocannabinoid system (ECS) regulates hormonal...

Read more
NEI Highlights Dr. Angela Fisher and Queer Safety Panel at
Healthcare & PharmaceuticalEnvironmental, Social and Governance

NEI Highlights Dr. Angela Fisher and Queer Safety Panel at "Celebrate & Connect" Grand Opening Wellness Event

December 3, 2025 6:00 AM

The Neurodivergent Empowerment Institute (NEI) will feature founder Angela Fisher, PhD, in a cornerstone session at its upcoming "Celebrate & Connect" Grand Opening Wellness Event on Sunday, December 14, 2025, at 2200 2nd Ave S, Suite 134, St. Petersburg, FL. Dr. Fisher will participate in and help lead a dedicated panel on queer safety in clinical, educational, and wellness settings, titled: "Queer Safety: Building Truly Affirming Systems for...

Read more
AlzeCure Receives Payment of EU Grant for Phase 2 Clinical Trial with NeuroRestore ACD856 for Alzheimer's Disease
Healthcare & PharmaceuticalCompany Update

AlzeCure Receives Payment of EU Grant for Phase 2 Clinical Trial with NeuroRestore ACD856 for Alzheimer's Disease

December 3, 2025 4:15 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a pharmaceutical company that develops candidate drugs for diseases affecting the nervous system, focusing on Alzheimer's disease and pain, announced today that the company has received the first payment of a grant of EUR 2.5 million from the European Innovation Council (EIC). The funding will enable a Phase IIa clinical study with the company's innovative drug candidate NeuroRestore ACD856 for...

Read more
Bioz Stars Awards 2025: Honoring Global Leaders Driving the Future of Scientific Innovation
Healthcare & PharmaceuticalPartnerships

Bioz Stars Awards 2025: Honoring Global Leaders Driving the Future of Scientific Innovation

December 3, 2025 4:00 AM

Bioz, Inc., the world's leading AI-powered platform for scientific research and evidence-based product recommendations, is proud to announce the winners of the Bioz Stars Awards 2025, recognizing the most innovative and impactful suppliers of scientific instruments, tools, reagents, and technologies across multidisciplinary scientific research. Now in its newest edition, the Bioz Stars Awards continue to serve as a trusted industry benchmark,...

Read more
President Trump Fixing DEA Marijuana Policy: Defies Logic, Law, and Science, Says MMJ International Holdings
Healthcare & PharmaceuticalCompany Update

President Trump Fixing DEA Marijuana Policy: Defies Logic, Law, and Science, Says MMJ International Holdings

December 3, 2025 3:30 AM

MMJ International Holdings, a pharmaceutical developer of a fully federally compliant, natural cannabinoid pharmaceutical for Huntington's Disease and Multiple Sclerosis, today released a sharply critical analysis of the Drug Enforcement Administration's marijuana research policies-calling them "mathematically impossible, legally contradictory, and scientifically indefensible." For seven years, MMJ has been trapped in a bureaucratic paradox...

Read more
Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension
Healthcare & PharmaceuticalCompany Update

Pentixapharm Advances Regulatory Preparations for Phase 3 PANDA Study with Radiodiagnostic Candidate 68Ga-PentixaFor in Hypertension

December 3, 2025 2:20 AM

Pentixapharm Holding AG (Frankfurt Prime Standard:PTP), a clinical-stage biotech developing first-in-class radiopharmaceuticals, has received encouraging feedback from a TypeB pre‑IND meeting with the U.S. Food and Drug Administration (FDA). The discussion addressed key elements of Pentixapharm's planned Phase 3 PANDA study with [ 68 Ga]Ga-PentixaFor, a CXCR4-directed radiodiagnostic intended to significantly improve the diagnostic pathway for...

Read more
Taurus TRT Complete Guide: Pricing, Process & How to Get Started
Healthcare & PharmaceuticalAdvertorial

Taurus TRT Complete Guide: Pricing, Process & How to Get Started

December 2, 2025 9:00 PM

Taurus TRT Complete Program Guide December 2025: Step-by-Step Process, Transparent Pricing, and Getting Started with Online Testosterone Replacement Therapy Comprehensive guide to TaurusMeds telehealth testosterone therapy including complete cost breakdown, treatment protocols, insurance considerations, and how to begin online TRT through board-certified physicians Visit the official Taurus Medical website to begin your confidential testosterone...

Read more
Electronic Caregiver Positions Addison Care as a Transformative Enablement Platform for CMS's New ACCESS Model
Healthcare & PharmaceuticalCompany Update

Electronic Caregiver Positions Addison Care as a Transformative Enablement Platform for CMS's New ACCESS Model

December 2, 2025 7:15 PM

Following CMS's announcement of the new ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions), Electronic Caregiver, Inc. (ECG) announced its intention to collaborate with eligible Medicare Part B providers and health organizations once CMS releases its list of participating entities in 2026. The ACCESS Model is designed to modernize chronic disease management by incentivizing continuous, tech-enabled care and rewarding...

Read more
Synaptigen Reviews (URGENT REPORT) Does This Sugar-Buildup Fix Really Improve Memory & Cognitive Clarity?
Healthcare & PharmaceuticalAdvertorial

Synaptigen Reviews (URGENT REPORT) Does This Sugar-Buildup Fix Really Improve Memory & Cognitive Clarity?

December 2, 2025 5:15 PM

In 2025 and beyond, cognitive supplements are under more scrutiny than ever, especially formulas claiming to clear "sugar buildup" from neurons, a mechanism increasingly discussed in functional medicine circles. Our investigative review of Synaptigen examines whether this gut-to-brain formula offers more than the usual nootropic promises. With rising reports of digital fatigue, disrupted focus, and early memory decline tied to glucose stress in...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?